Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 2018; Volume 94,Issue 1

Minireview

  • Open Access
    PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis
    Qiao Yi Chen and Max Costa
    Molecular Pharmacology July 2018, 94 (1) 784-792; DOI: https://doi.org/10.1124/mol.118.112268

Articles

  • You have access
    Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1
    Kaia K. Hampton, Katie Anderson, Hilaree Frazier, Olivier Thibault and Rolf J. Craven
    Molecular Pharmacology July 2018, 94 (1) 665-673; DOI: https://doi.org/10.1124/mol.117.110510
  • You have access
    Ligand-Specific Signaling Profiles and Resensitization Mechanisms of the Neuromedin U2 Receptor
    Khaled Alhosaini, Omar Bahattab, Heider Qassam, R. A. John Challiss and Gary B. Willars
    Molecular Pharmacology July 2018, 94 (1) 674-688; DOI: https://doi.org/10.1124/mol.117.111070
  • You have access
    Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity
    Ling Zou, Adrian Stecula, Anshul Gupta, Bhagwat Prasad, Huan-Chieh Chien, Sook Wah Yee, Li Wang, Jashvant D. Unadkat, Simone H. Stahl, Katherine S. Fenner and Kathleen M. Giacomini
    Molecular Pharmacology July 2018, 94 (1) 689-699; DOI: https://doi.org/10.1124/mol.117.111153
  • You have access
    Thyroid Hormones Are Transport Substrates and Transcriptional Regulators of Organic Anion Transporting Polypeptide 2B1
    Henriette E. Meyer zu Schwabedissen, Celio Ferreira, Anima M. Schaefer, Mouhssin Oufir, Isabell Seibert, Matthias Hamburger and Rommel G. Tirona
    Molecular Pharmacology July 2018, 94 (1) 700-712; DOI: https://doi.org/10.1124/mol.117.111161
  • Open Access
    Cysteine Scanning Mutagenesis of TM4b-4c Loop of Glutamate Transporter EAAT1 Reveals Three Conformationally Sensitive Residues
    Wenlong Zhang, Xiuping Zhang and Shaogang Qu
    Molecular Pharmacology July 2018, 94 (1) 713-721; DOI: https://doi.org/10.1124/mol.117.111245
  • Efficient High-Throughput Screening by Endoplasmic Reticulum Ca<sup>2+</sup> Measurement to Identify Inhibitors of Ryanodine Receptor Ca<sup>2+</sup>-Release Channels
    You have access
    Efficient High-Throughput Screening by Endoplasmic Reticulum Ca2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca2+-Release Channels
    Takashi Murayama, Nagomi Kurebayashi, Mari Ishigami-Yuasa, Shuichi Mori, Yukina Suzuki, Ryunosuke Akima, Haruo Ogawa, Junji Suzuki, Kazunori Kanemaru, Hideto Oyamada, Yuji Kiuchi, Masamitsu Iino, Hiroyuki Kagechika and Takashi Sakurai
    Molecular Pharmacology July 2018, 94 (1) 722-730; DOI: https://doi.org/10.1124/mol.117.111468
  • You have access
    Restoration of Physiological Expression of 5-HT6 Receptor into the Primary Cilia of Null Mutant Neurons Lengthens Both Primary Cilia and Dendrites
    Atom J. Lesiak, Matthew Brodsky, Nathalie Cohenca, Alexandra G. Croicu and John F. Neumaier
    Molecular Pharmacology July 2018, 94 (1) 731-742; DOI: https://doi.org/10.1124/mol.117.111583
  • You have access
    Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
    Alex Straiker, Michaela Dvorakova, Anaelle Zimmowitch and Ken Mackie
    Molecular Pharmacology July 2018, 94 (1) 743-748; DOI: https://doi.org/10.1124/mol.118.111864
  • You have access
    A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells
    Liming Chen, Yifan Bao, Stephanie C. Piekos, Kexin Zhu, Lirong Zhang and Xiao-bo Zhong
    Molecular Pharmacology July 2018, 94 (1) 749-759; DOI: https://doi.org/10.1124/mol.118.112235
  • You have access
    The Temperature Dependence of Kinetics Associated with Drug Block of hERG Channels Is Compound-Specific and an Important Factor for Proarrhythmic Risk Prediction
    Monique J. Windley, William Lee, Jamie I. Vandenberg and Adam P. Hill
    Molecular Pharmacology July 2018, 94 (1) 760-769; DOI: https://doi.org/10.1124/mol.117.111534
  • You have access
    Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M1 Muscarinic Acetylcholine Receptors
    Emma T. van der Westhuizen, Arthur Spathis, Elham Khajehali, Manuela Jörg, Shailesh N. Mistry, Ben Capuano, Andrew B. Tobin, Patrick M. Sexton, Peter J. Scammells, Celine Valant and Arthur Christopoulos
    Molecular Pharmacology July 2018, 94 (1) 770-783; DOI: https://doi.org/10.1124/mol.118.111633
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 94 (1)
Molecular Pharmacology
Vol. 94, Issue 1
1 Jul 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics